These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8102676

  • 21. Human trials of AIDS vaccines: current status and future directions.
    Koff WC, Fauci AS.
    AIDS; 1989; 3 Suppl 1():S125-9. PubMed ID: 2558684
    [No Abstract] [Full Text] [Related]

  • 22. A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.
    Pialoux G, Excler JL, Rivière Y, Gonzalez-Canali G, Feuillie V, Coulaud P, Gluckman JC, Matthews TJ, Meignier B, Kieny MP.
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):373-81. PubMed ID: 7598771
    [Abstract] [Full Text] [Related]

  • 23. [AIDS--HIV envelope protein improves vaccination response].
    GURTLER L.
    Fortschr Med; 1991 Dec 10; 109(35):10-1. PubMed ID: 1774002
    [No Abstract] [Full Text] [Related]

  • 24. Vaccination with gp160 in HIV.
    Oyaizu N, Chirmule N, Pahwa S.
    N Engl J Med; 1992 Jan 30; 326(5):347; author reply 348. PubMed ID: 1728747
    [No Abstract] [Full Text] [Related]

  • 25. Vaccination with gp160 in HIV.
    Stanberry LR, Bernstein DI, Myers MG.
    N Engl J Med; 1992 Jan 30; 326(5):347-8. PubMed ID: 1728748
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Army to test only MicroGeneSys vaccine.
    Science; 1993 Aug 13; 261(5123):819. PubMed ID: 8346429
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.
    Kundu SK, Katzenstein D, Moses LE, Merigan TC.
    Proc Natl Acad Sci U S A; 1992 Dec 01; 89(23):11204-8. PubMed ID: 1360665
    [Abstract] [Full Text] [Related]

  • 38. Human studies in the development of human immunodeficiency virus vaccines.
    Dolin R.
    J Infect Dis; 1995 Nov 01; 172(5):1175-83. PubMed ID: 7594651
    [Abstract] [Full Text] [Related]

  • 39. Vaccine against AIDS?
    Lancet; 1994 Feb 26; 343(8896):493-4. PubMed ID: 7906752
    [No Abstract] [Full Text] [Related]

  • 40. The true cost of a free AIDS vaccine.
    Science; 1993 Aug 27; 261(5125):1107. PubMed ID: 8356442
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.